Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost preservative-free versus timolol in pediatric glaucoma
2011-003278-10Phase 3
- Sponsor
- Allergan
- Start
- Sep 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Glaucoma comparing Bimatoprost preservative-free with Timolol active control (2 arms). Primary endpoint: Change from baseline in study eye intraocular pressure at Week 12 (Hour 2).
02
Drugs
bimatoprosttimolol
03
Conditions
Glaucoma
Beyond the preview
Go deeper on 2011-003278-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003278-10.